Indication

Anemia due to bleeding uterine leiomyoma

Anemia due to bleeding uterine leiomyoma is a secondary hematologic complication arising from excessive, abnormal uterine bleeding—most frequently heavy or prolonged menstrual bleeding—caused by benign smooth muscle neoplasms of the myometrium. Read more about Anemia due to bleeding uterine leiomyoma

3 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Anemia due to bleeding uterine leiomyoma therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Anemia due to bleeding uterine leiomyoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anemia due to bleeding uterine leiomyoma.

Anemia due to bleeding uterine leiomyoma is a secondary hematologic complication arising from excessive, abnormal uterine bleeding—most frequently heavy or prolonged menstrual bleeding—caused by benign smooth muscle neoplasms of the myometrium.

Primarily affecting individuals of reproductive age, particularly perimenopausal females, the condition is driven by leiomyomas (especially submucosal or large intramural subtypes) that alter uterine vascularity, disrupt normal hemostatic myometrial contractility, and expand the endometrial surface area.

This chronic or acute blood loss depletes systemic iron stores faster than erythropoiesis can compensate, culminating in iron-deficiency anemia characterized by decreased hemoglobin and hematocrit, microcytosis, hypochromia, and clinical manifestations such as pallor, fatigue, dyspnea, and tachycardia.

Personalize your experience

Follow Anemia due to bleeding uterine leiomyoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it